Cyp3a Inducers + Zanubrutinib Interaction
Majorinteraction on record
Description
Coadministration decreases zanubrutinib Cmax and AUC, which may reduce BRUKINSA efficacy. Avoid coadministration; if unavoidable, increase dosage.
Mechanism
CYP3A induction decreases zanubrutinib exposure
Source: NLP:zanubrutinib